Article
Trimethoprim resistance in Escherichia coli exhibits an allele-specific growth advantage
3 Jun 2025
Abstract excerpt
Introduction. The antibiotic trimethoprim has been used to treat urinary tract infection (UTI) since ~1962. Alongside the nitrofurantoin, there are still justified reasons for trimethoprim use, especially in non-pregnant women. Trimethoprim resistance is commonly the result of acquiring the trimethoprim-insensitive dihydrofolate reductase gene: dfrA. Assessment of clinical Escherichia coli isolates from two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
